Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Down Syndrome
|
NINDS
|
5K99NS057906-02
|
|
Imaging nerve growth factor signal transduction in live neurons
|
CUI, BIANXIAO
|
STANFORD UNIVERSITY
|
CA
|
$59,238
|
Down Syndrome
|
NCI
|
5R01CA111778-04
|
|
Molecular Studies of Down Syndrome Leukemia
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$231,698
|
Down Syndrome
|
NHLBI
|
5R01HL083300-02
|
|
Genetic basis for congenital heart defects
|
REEVES, ROGER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$1,101,599
|
Down Syndrome
|
NIA
|
1K01AG031296-01
|
|
Title Omitted
|
YANOWITZ, JUDITH
|
CARNEGIE INSTITUTION OF WASHINGTON, D.C.
|
DC
|
$105,192
|
Down Syndrome
|
NICHD
|
1R01HD057564-01
|
|
Perinatal choline therapy in a mouse model of Down Syndrome & Alzheimer's Disease
|
STRUPP, BARBARA
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$623,872
|
Down Syndrome
|
NINDS
|
5R01NS048263-05
|
|
Altered Glial Calcium Signaling in Neurodegeneration
|
GOLOVINA, VERA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$260,490
|
Down Syndrome
|
NHLBI
|
1R01HL091519-01A1
|
|
Genetic Dissection of Trisomy 21
|
YU, EUGENE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$417,369
|
Down Syndrome
|
NICHD
|
1R01HD055391-01A1
|
|
NFAT Signaling and Down Syndrome
|
CRABTREE, GERALD
|
STANFORD UNIVERSITY
|
CA
|
$277,998
|
Down Syndrome
|
NICHD
|
5R01HD038466-08
|
|
Mitochondrial Dysfunction in Down's Syndrome
|
BUSCIGLIO, JORGE
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$188,650
|
Down Syndrome
|
NICHD
|
5R01HD047656-04
|
|
Age and Cognition in a Mouse Model of Down Syndrome
|
WENGER, GALEN
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$246,479
|
Down Syndrome
|
NICHD
|
5R01HD024356-18
|
|
Language Development in Fragile X Syndrome
|
ABBEDUTO, LEONARD
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$537,773
|
Down Syndrome
|
NICHD
|
5R01HD043960-05
|
|
The role of Mnbk in Downs Syndrome brain development and aging
|
WEGIEL, JERZY
|
INSTITUTE FOR BASIC RES IN DEV DISABIL
|
NY
|
$521,790
|
Down Syndrome
|
NINDS
|
1F31NS060517-01A1
|
|
Effects of neural progenitor cell transplantation in neonatal Ts65Dn mice.
|
RACHUBINSKI, ANGELA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$27,792
|
Down Syndrome
|
NICHD
|
5R01HD038819-07
|
|
Pragmatic Skills of Young Males and Females with Fragile X Syndrome
|
ROBERTS, JOANNE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$517,218
|
Down Syndrome
|
NIGMS
|
1F31GM083452-01
|
|
Genome-wide recombination as a risk factor for nondisjunction
|
HOLLIS, NATASHA
|
EMORY UNIVERSITY
|
GA
|
$28,062
|
Down Syndrome
|
NICHD
|
5R01HD028088-16
|
|
GENETIC ANALYSIS OF HIRSCHSPRUNG DISEASE
|
CHAKRAVARTI, ARAVINDA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$445,201
|
Down Syndrome
|
NCI
|
5R01CA111551-04
|
|
Singleminded-2 in Mammary Gland and Breast Cancer
|
PORTER, WESTON
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$213,741
|
Down Syndrome
|
NINDS
|
5R01NS055371-02
|
|
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down Syndrome
|
MOBLEY, WILLIAM
|
STANFORD UNIVERSITY
|
CA
|
$369,547
|
Down Syndrome
|
NICHD
|
5R01HD038979-09
|
|
Trisomy 21: Risk Factors for Chromosome Non-disjunction
|
SHERMAN, STEPHANIE
|
EMORY UNIVERSITY
|
GA
|
$663,427
|
Down Syndrome
|
NCI
|
5R01HD038384-08
|
|
Genomic Approaches to Aneuploidy
|
REEVES, ROGER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$117,044
|
Down Syndrome
|
NICHD
|
5R01HD038384-08
|
|
Genomic Approaches to Aneuploidy
|
REEVES, ROGER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$520,333
|
Down Syndrome
|
NCCAM
|
5R01AG016381-07
|
|
VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME
|
DALTON, ARTHUR
|
INSTITUTE FOR BASIC RES IN DEV DISABIL
|
NY
|
$196,000
|
Down Syndrome
|
NIA
|
5R01AG016381-07
|
|
VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME
|
DALTON, ARTHUR
|
INSTITUTE FOR BASIC RES IN DEV DISABIL
|
NY
|
$662,588
|
Down Syndrome
|
NICHD
|
5R01AG016381-07
|
|
VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME
|
DALTON, ARTHUR
|
INSTITUTE FOR BASIC RES IN DEV DISABIL
|
NY
|
$220,500
|
Down Syndrome
|
NCI
|
5R01CA101774-06
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$305,841
|
Down Syndrome
|
NIA
|
5R01AG012122-13
|
|
An animal model for age-related degeneration
|
GRANHOLM-BENTLEY, ANN-CHARLOTTE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$256,328
|
Down Syndrome
|
NICHD
|
1R01HD056235-01A1
|
|
Systems Biology for Studies of Cognition in Down Syndrome
|
GARDINER, KATHELEEN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$499,742
|
Down Syndrome
|
NCI
|
5R01CA120772-02
|
|
Molecular and Pharmacologic Correletes of Acute Myeloid Leukemia in Down Syndrome
|
TAUB, JEFFREY
|
WAYNE STATE UNIVERSITY
|
MI
|
$406,183
|
Down Syndrome
|
NICHD
|
2R01HD035612-10A1
|
|
The Development of Joint Attention After Infancy
|
ADAMSON, LAUREN
|
GEORGIA STATE UNIVERSITY
|
GA
|
$307,063
|
Down Syndrome
|
NICHD
|
1R21HD054347-01A2
|
|
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
|
SHEEN, VOLNEY
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$212,500
|
Down Syndrome
|
NICHD
|
5R21HD056195-02
|
|
Tau missplicing caused by RNA processing proteins located on chromosome 21
|
ANDREADIS, ATHENA
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$198,429
|
Down Syndrome
|
NIA
|
5R01AG014673-09
|
|
Epidemiology of menopause and dementia in Down syndrome
|
SCHUPF, NICOLE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$481,787
|
Down Syndrome
|
NIDCD
|
5R01DC008640-02
|
|
Treatment of Speech Disorders in Children with Down Syndrome
|
CAMARATA, STEPHEN
|
VANDERBILT UNIVERSITY
|
TN
|
$416,287
|
Down Syndrome
|
NIA
|
5F31AG029787-02
|
|
APP Metabolism in Transgenic Down Syndrome Mouse Models
|
CHOI, JENNIFER
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$40,972
|
Down Syndrome
|
NICHD
|
5R37HD029957-16
|
|
Early Development with Williams or Down Syndrome
|
MERVIS, CAROLYN
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$307,339
|
Down Syndrome
|
NINDS
|
5F31NS060388-02
|
|
Differential CpG Island Methylation in Down Syndrome
|
MILLER, NATHANIEL
|
HUGO W. MOSER RES INST KENNEDY KRIEGER
|
MD
|
$37,092
|
Down Syndrome
|
NICHD
|
5F32HD055745-02
|
|
Retrograde Transport at the Crossroads of Cognitive Delcine and Neurodegeneration
|
MALONEY, MICHAEL
|
STANFORD UNIVERSITY
|
CA
|
$46,826
|
Down Syndrome
|
NINDS
|
5K99NS052524-02
|
|
Role of nebula/DSCR1 in mitochondria
|
CHANG, KAREN
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$90,000
|
Down Syndrome
|
NHLBI
|
1K08HL093290-01
|
|
Genetic modulators of erythro-megakaryocytic development
|
CHOU, STELLA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$133,920
|
Down Syndrome
|
NIGMS
|
1R01GM085548-01
|
|
Is Chromosome Therapy Possible for Down Syndrome and Other Karyotypic Imbalances?
|
LAWRENCE, JEANNE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$327,083
|
Down Syndrome
|
NICHD
|
1R01HD055457-01A2
|
|
Role of PIP2 metabolism imbalance in Down Syndrome
|
DI PAOLO, GILBERT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$342,125
|
Down Syndrome
|
NIDCD
|
2R01DC003311-06A1
|
|
Sensorimotor Control of the Human Orofacial System
|
BARLOW, STEVEN
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$534,917
|
Down Syndrome
|
NIA
|
1R03AG029966-01A2
|
|
The involvement of Adapt78 in Alzheimer's disease and Down Syndrome
|
CRAWFORD, DANA
|
ALBANY MEDICAL COLLEGE
|
NY
|
$66,725
|
Down Syndrome
|
NICHD
|
1R01HD057029-01A1
|
|
Genome-wide recombination profiles in oocytes with chromosome 21 nondisjunction
|
SHERMAN, STEPHANIE
|
EMORY UNIVERSITY
|
GA
|
$287,378
|
Down Syndrome
|
NICHD
|
2R01HD044935-06A1
|
|
Speech of Young Males with Fragile X Syndrome
|
ROBERTS, JOANNE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$341,868
|
Down Syndrome
|
NHLBI
|
1F32HL091639-01A1
|
|
The Role of Dyrk1a in the Pathogenesis of Congenital Heart Disease
|
TWU, KAREN
|
STANFORD UNIVERSITY
|
CA
|
$49,646
|
Down Syndrome
|
NIA
|
5P01AG009464-17
|
0009
|
EFFECTS ON AB ON SYNAPTIC TRANMISSION AND PLASTICITY
|
GREENGARD, PAUL
|
ROCKEFELLER UNIVERSITY
|
NY
|
$327,606
|
Down Syndrome
|
NHLBI
|
5P50HL074728-05
|
0003
|
REGULATION OF VALVULOSEPTAL DEVELOPMENT BY DSCR1
|
YUTZEY, KATHERINE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$330,561
|
Down Syndrome
|
NIDCD
|
1R03DC009301-01A1
|
|
Nonlinguistic Vocalizations in Autism: Acoustic Cry Analysis in Early Infancy
|
SHEINKOPF, STEPHEN
|
WOMEN AND INFANTS HOSPITAL-RHODE ISLAND
|
RI
|
$73,329
|
Down Syndrome
|
NIA
|
5P50AG016573-09
|
9001
|
CORE--CLINICAL
|
KAWAS, CLAUDIA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$432,896
|
Down Syndrome
|
NIA
|
5P01AG017617-09
|
0005
|
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY
|
MATHEWS, PAUL
|
NEW YORK STATE CNCL FOR MTL HYGIENE PLNG
|
NY
|
$375,840
|
Down Syndrome
|
NIA
|
5P01AG017617-09
|
0008
|
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD
|
GINSBERG, STEPHEN
|
NEW YORK STATE CNCL FOR MTL HYGIENE PLNG
|
NY
|
$333,362
|
Down Syndrome
|
NIA
|
5P01AG017617-09
|
9001
|
TRANSGENIC CORE
|
LEVY, EFRAT
|
NEW YORK STATE CNCL FOR MTL HYGIENE PLNG
|
NY
|
$207,945
|
Down Syndrome
|
NIDCD
|
3R01DC008640-02S1
|
|
Treatment of Speech Disorders in Children with Down Syndrome
|
CAMARATA, STEPHEN
|
VANDERBILT UNIVERSITY
|
TN
|
$83,636
|
Down Syndrome
|
NICHD
|
5P01HD025995-18
|
0001
|
GUIDING VISUAL ATTENTION TO ENHANCE DISCRIMINATION LEARNING
|
CARLIN, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$142,587
|
Down Syndrome
|
NICHD
|
5P01HD025995-18
|
0003
|
MULTIMODAL ANALYSES OF FACE PROCESSING IN AUTISM & DOWN SYNDROME
|
MITCHELL, TERESA
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$152,927
|
Down Syndrome
|
NINDS
|
4R00NS057906-03
|
|
Imaging NGF signal transduction in live neurons
|
CUI, BIANXIAO
|
STANFORD UNIVERSITY
|
CA
|
$247,126
|
Down Syndrome
|
NCRR
|
5M01RR008084-15
|
7924
|
BLOOD EXPRESSION PROFILES IN CHILDREN WITH DOWN SYNDROME
|
MOLLOY, CYNTHIA
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$7,803
|
Down Syndrome
|
NCRR
|
5M01RR000827-33
|
7100
|
CLINICAL TRIAL: DOWN SYNDROME AND ALZHEIMER DISEASE: ANTIOXIDANT TRIAL
|
LOTT, IRA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$21,661
|
Down Syndrome
|
NCRR
|
5M01RR000827-33
|
7130
|
DIAGNOSIS OF ALZHEIMER DISEASE IN DOWN SYNDROME BY TELEMEDICINE
|
LOTT, IRA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$6,869
|
Down Syndrome
|
NCRR
|
2M01RR001066-31
|
8302
|
COMPARISON OF BODY COMPOSITION BY DEXA AND BIOELECTRICAL IMPEDANCE IN ADOLESCEN
|
FLEMING, RICHARD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$324
|